Work

MUC5AC profiling as a biomarker for predicting post-recurrence outcomes and guiding precision therapy in pancreatic ductal adenocarcinoma (PDA).

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16374

Authors: Ashwini K Esnakula, Ravi Kumar Paluri, Kannan Thanikachalam, Lianbo Yu, Wancai Yang, Ashish Manne

Institutions: The Ohio State University, Wake Forest University, Roswell Park Comprehensive Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410812979

FWCI:

Cites:

Cited by:

Related to: 10